BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23151067)

  • 1. Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.
    Tchantchou F; Zhang Y
    J Neurotrauma; 2013 Apr; 30(7):565-79. PubMed ID: 23151067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WWL70 attenuates PGE
    Tanaka M; Moran S; Wen J; Affram K; Chen T; Symes AJ; Zhang Y
    J Neuroinflammation; 2017 Jan; 14(1):7. PubMed ID: 28086912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
    Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
    J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The α/β-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids.
    Bottemanne P; Paquot A; Ameraoui H; Alhouayek M; Muccioli GG
    FASEB J; 2019 Jun; 33(6):7635-7646. PubMed ID: 30896979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury.
    Katz PS; Sulzer JK; Impastato RA; Teng SX; Rogers EK; Molina PE
    J Neurotrauma; 2015 Mar; 32(5):297-306. PubMed ID: 25166905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6.
    Alhouayek M; Masquelier J; Cani PD; Lambert DM; Muccioli GG
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17558-63. PubMed ID: 24101490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury.
    Tchantchou F; Tucker LB; Fu AH; Bluett RJ; McCabe JT; Patel S; Zhang Y
    Neuropharmacology; 2014 Oct; 85():427-39. PubMed ID: 24937045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
    Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
    Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury.
    Piro JR; Suidan GL; Quan J; Pi Y; O'Neill SM; Ilardi M; Pozdnyakov N; Lanz TA; Xi H; Bell RD; Samad TA
    J Neuroinflammation; 2018 May; 15(1):142. PubMed ID: 29759062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.
    Marrs WR; Blankman JL; Horne EA; Thomazeau A; Lin YH; Coy J; Bodor AL; Muccioli GG; Hu SS; Woodruff G; Fung S; Lafourcade M; Alexander JP; Long JZ; Li W; Xu C; Möller T; Mackie K; Manzoni OJ; Cravatt BF; Stella N
    Nat Neurosci; 2010 Aug; 13(8):951-7. PubMed ID: 20657592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Novel Monoacylglycerol Lipase Inhibitor MJN110 Suppresses Neuroinflammation, Normalizes Synaptic Composition and Improves Behavioral Performance in the Repetitive Traumatic Brain Injury Mouse Model.
    Selvaraj P; Tanaka M; Wen J; Zhang Y
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors.
    Savinainen JR; Saario SM; Laitinen JT
    Acta Physiol (Oxf); 2012 Feb; 204(2):267-76. PubMed ID: 21418147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity.
    Kokona D; Spyridakos D; Tzatzarakis M; Papadogkonaki S; Filidou E; Arvanitidis KI; Kolios G; Lamani M; Makriyannis A; Malamas MS; Thermos K
    Neuropharmacology; 2021 Mar; 185():108450. PubMed ID: 33450278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.
    Griebel G; Pichat P; Beeské S; Leroy T; Redon N; Jacquet A; Françon D; Bert L; Even L; Lopez-Grancha M; Tolstykh T; Sun F; Yu Q; Brittain S; Arlt H; He T; Zhang B; Wiederschain D; Bertrand T; Houtmann J; Rak A; Vallée F; Michot N; Augé F; Menet V; Bergis OE; George P; Avenet P; Mikol V; Didier M; Escoubet J
    Sci Rep; 2015 Jan; 5():7642. PubMed ID: 25560837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocytes differentially express endocannabinoid-glycerol lipases and hydrolyze 2-arachidonoyl-glycerol and its metabolites from the 15-lipoxygenase and cyclooxygenase pathways.
    Turcotte C; Dumais É; Archambault AS; Martin C; Blanchet MR; Bissonnette É; Boulet LP; Laviolette M; Di Marzo V; Flamand N
    J Leukoc Biol; 2019 Dec; 106(6):1337-1347. PubMed ID: 31556464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury.
    Zhang J; Teng Z; Song Y; Hu M; Chen C
    J Cereb Blood Flow Metab; 2015 Mar; 35(3):443-53. PubMed ID: 25492114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of monoacylglycerol lipase as novel analgesics.
    Hohmann AG
    Br J Pharmacol; 2007 Mar; 150(6):673-5. PubMed ID: 17293886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.
    Blankman JL; Simon GM; Cravatt BF
    Chem Biol; 2007 Dec; 14(12):1347-56. PubMed ID: 18096503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.